Science-Backed Supplement Guidance. Clear Answers. Real Results.
Welcome to VerifiedSupps
Your trusted source for clear, simple, and science-based supplement information. No marketing hype. No exaggerated claims. Just research, real-world experience, and straightforward guidance you can actually use.
Ingredient Guides
Breakdowns of what each ingredient does, why it works, and what the research says.
Supplement Reviews
Honest reviews focused on dosage, effectiveness, and scientific evidence.
Science-Based Stacks
Performance stacks for pump, focus, recovery, inflammation, and overall health.
Calm & Focus
Breakdowns of what each ingredient does, why it works, and what the research says.
Longevity
Performance stacks for pump, focus, recovery, inflammation, and overall health.
Muscle & Performance
Performance stacks for pump, focus, recovery, inflammation, and overall health.
Our Mission
To cut through the noise and make supplement science easy to understand through research-based explanations and real-world experience.
Start With Our Most Popular Guides
Placeholder: Your trusted source for clear, simple, and science-based supplement information. No marketing hype. No exaggerated claims. Just research, real-world experience, and straightforward guidance you can actually use.
Orforglipron vs Rybelsus: How Lilly’s Oral GLP-1 Pill Compares
Oral GLP-1 Comparison Orforglipron vs Rybelsus: How Lilly’s Oral GLP-1 Pill Compares Orforglipron and Rybelsus are both once-daily oral GLP-1 receptor agonists, but they are not the same type of drug or used in the same way. Orforglipron is Lilly’s
Orforglipron for Weight Loss: Results, Side Effects, and Current Status
Oral GLP-1 Weight-Loss Medication Orforglipron for Weight Loss: Results, Side Effects, and Current Status Orforglipron is an oral GLP-1 receptor agonist approved by the FDA under the brand name Foundayo for chronic weight management in adults with obesity, or adults
Ribupatide for Weight Loss: Oral and Injectable GLP-1/GIP Results
Investigational Weight-Loss Drugs Ribupatide for Weight Loss: Oral and Injectable GLP-1/GIP Results Ribupatide is an investigational dual GLP-1/GIP receptor agonist being developed in both once-weekly injectable and once-daily oral forms for obesity and overweight. The injectable version is further along
Is Retatrutide Approved Yet? FDA Status, Availability, and Timeline
FDA Status & Drug Availability Is Retatrutide Approved Yet? FDA Status, Availability, and Timeline No. As of May 19, 2026, retatrutide is not FDA-approved for weight loss, type 2 diabetes, or any other condition. It remains an investigational once-weekly triple
CT-388 for Weight Loss: Results, Side Effects, and Current Status
Investigational Weight-Loss Drugs CT-388 for Weight Loss: Results, Side Effects, and Current Status CT-388, also called enicepatide, is an investigational once-weekly injectable GLP-1/GIP receptor agonist being developed by Roche and Genentech for obesity, type 2 diabetes, and related metabolic conditions.
GHK-Cu Copper Peptide: Benefits, Science, and Best Skincare Serums
Skin Peptides & Cosmetic Actives GHK-Cu Copper Peptide: The Complete 2026 Guide to Benefits, Science & Best Skincare Serums GHK-Cu, also called copper tripeptide-1, is a copper-binding peptide used in skincare for firmness, texture, fine lines, and skin repair support.